Warning Letter Roundup: Four Companies Hit for GMP Violations

Drug GMP Report
A A
The FDA issued warning letters to four drugmakers for various GMP violations at their facilities, including quality unit shortcomings.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00